Alopecia Areata.
Conditions
Interventions
Intervention 1: Intervention group: a vial of methotrexate containing 25 mg/ml is used. After septic procedures, methotrexate is injected intradermally in the lesion itself and one centimeter around i
Sponsors
Vice chancellor of Research and Technology,Tehran University of Medical Sciences and Health Services
Eligibility
Sex/Gender
All
Age
16 Years to 60 Years
Inclusion criteria
Inclusion criteria: Adult patients (aged 16-60 years) Patients with alopecia areata who have less than 20% involvement of the scalp have not received any treatment for AA in the past 1 month.
Exclusion criteria
Exclusion criteria: Children and patients under 16 years, pregnant and lactating women, chronic patients including patients with liver or blood disorders, patients with immunodeficiency, infectious disease patients with diffuse types (alopecia totalis, alopecia universalis and more than 20%) and positive pull tests that are candidates for systemic treatment patients who were treated for alopecia areata during the previous month
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Alopecia Areata severity index. Timepoint: The beginning of the study, one month, two months, three months, six months after the start of the study. Method of measurement: Viewing Dermoscopy criteria. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNarges Ghandi
Tehran University of Medical Sciences
Outcome results
None listed